The sales of syringes and cannula in MENA are estimated to be worth USD 1,592.2 million in 2024 and are anticipated to reach a value of USD 2,824.7 million by 2034. Sales are projected to rise at a CAGR of 5.9% over the forecast period between 2024 and 2034. The revenue generated by syringes in 2023 was USD 1,108.1 million. The industry is anticipated to exhibit a Y-o-Y growth of 5.9% in 2024.
Syringes accounted for a majority shares of MENA syringes and cannula market and is poised to dominate the market with more than 73.7% of the market share. Rising prevalence of chronic diseases such as diabetes and cancer, which require regular injections and the increasing adoption of injectable drugs for the management of painful and other medical conditions contributes to the growth of the segment.
In addition to this, rapid urbanization, increase in healthcare spending in MENA region, growing adoption of advanced syringes and cannulas that have improved safety features are few other factors propelling the growth of the market in the region.
MENA Syringes & Cannula Industry Assessment
| Attributes | Key Insights |
|---|---|
| Historical Size, 2023 | USD 1,503.5 million |
| Estimated Size, 2024 | USD 1,592.2 million |
| Projected Size, 2034 | USD 2,824.7 million |
| Value-based CAGR (2024 to 2034) | 5.9% |
The increase in use of injectable drugs, intravenous (IV) therapies, and the growing number of people undergoing medical procedures primarily contribute to the growth of the market. In addition to this, rising prevalence of chronic diseases such as diabetes, HIV/AIDS, and cancer, which require regular injections, further contributes to the growing demand for syringes and cannula in the market.
Growing healthcare infrastructure, increase in investment of private hospitals, and increasing medical tourism in the countries of MENA region such as UAE and Saudi Arabia which attracts patients from across the region. This influx in patients augments demand for medical supplies and further drives the growth of the syringes and cannula market in the region.
Healthcare providers and patients alike are aware of the importance of safe and sterile injection practices, which has led to an increased demand for high-quality, disposable syringes and cannulas that can reduce the risk of infections and other complications associated with reuse or improper cleaning of the syringes and cannulas. The World Health Organization has also published safety guidelines that are aimed to reduce the risk of needle-stick injuries among clinicians and adopt safer injection practices in their healthcare premises.
To meet this rising demand concerning its growing awareness among healthcare practitioners, manufacturers are emphasizing on introduction of safety-equipped devices, multi-chamber syringes, and superior lubrication technology that has improved safety and efficiency, which further contribute to increase in demand for disposable syringes and drive its growth in these flourishing market.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The below table presents the expected CAGR for the MENA syringes & cannula market over several semi-annual periods spanning from 2024 to 2034. In the first half (H1) of the decade from 2023 to 2033, the business is predicted to surge at a CAGR of 6.9%, followed by a slightly lower growth rate of 6.3% in the second half (H2) of the same decade.
| Particular | Value CAGR |
|---|---|
| H1 | 6.9% (2023 to 2033) |
| H2 | 6.3% (2023 to 2033) |
| H1 | 5.9% (2024 to 2034) |
| H2 | 5.5% (2024 to 2034) |
Moving into the subsequent period, from H1 2024 to H2 2034, the CAGR is projected to increase slightly to 5.9% in the first half and remain relatively moderate at 5.5% in the second half. In the first half (H1) the market witnessed a decrease of 100 BPS while in the second half (H2), the market witnessed a decrease of 110 BPS.
Rising Prevalence of Infectious Diseases and Other Medical Condition Anticipates the Growth of the Market
The rising prevalence of infectious disease in the MENA region are majorly attributed to the factors such as poverty, poor healthcare systems, and overcrowding. The common disease in the region are tuberculosis, dengue, malaria, and hepatitis B. The region also has a high incidence of respiratory infections and parasitic diseases such as schistosomiasis.
For instance, according to the statistics published by the World Health Organization in 2020, a total number of 230,121 cases of cholera were reported in Yemen. The statistics also stated that Somalia had 6,582 suspected cases of cholera in the same year.
In addition to this, the increase in number of a serious infection such as Human Immunodeficiency Virus (HIV) has also been observed in the region. The major reason for increase in HIV cases in the region is lack of education and knowledge on sexually transmitted diseases. For instance, according to the statistics published by the United Nations, the Middle East and North Africa (MENA) region has the highest number of new HIV infections globally, with an estimated 420,000 new cases in 2020 alone among which men are mostly affected accounting for 76.0% of the cases in the region.
These rising prevalence of infectious diseases in the region majorly surges the growing demand of syringes and cannula in the market.
Growing Advancements in Syringes and Cannulas Contributes to its Growing Adoption
The introduction of safety-equipped syringes, such as those with passive needle guards and upgraded retractable needle systems, has improved the prevention of needle-stick injuries and reduced the risk of unintentional needle stick injury.
Manufacturers are introducing advanced lubrication technology that have improved ease of use as compared to the traditional ones. This technology have also reduced the risk of needle stick injuries associated with syringes. Companies are also focusing on the development of novel smart syringes that can prevent contact induced infections when injected into muscles or skin.
In addition to this, the growing adoption of multi-chamber syringes with enhanced efficiency and safety of syringe use, particularly in the administration of multiple medications further propels the rising competition of developing advanced syringes and cannulas among operating players.
Dependency of MENA Region on Imports of Medical Supplies Constrains the Market Growth
MENA region is largely dependent on imports of medical supplies which leads hospitals and other healthcare facilities to incur higher costs on supplies such as syringes and cannulas. These costs are generally high due to the inclusion of high tariffs, shipping fees and currency fluctuations. These increased cost makes syringes and cannula less affordable to healthcare facilities operating in the countries which significantly hampers its adoption in the market and limits its growth in the market.
In addition to this, lack of availability of any strong local manufacturing player in the market further exacerbates the issue. Availability of only few domestic manufacturers the region struggles to meet the growing demand of medical supplies which makes them highly dependent on external suppliers.
These dependency on external suppliers exposes MENA region to intense competition among global suppliers that can hamper the growth of local businesses. These factors may also lead to increase in number of suppliers that are offering sub-standard medical supplies to the market that are inconsistence, affecting the reliability and safety of medical supplies.
Growing Awareness for the Injuries Caused Due to Syringes and Cannula
Growing safety awareness is a crucial issue in the MENA region. These injuries can be severe and life-threatening, and they often occur due to improper handling, storage, and disposal of medical equipment. To address this issue, various organizations and governments in the MENA region are implementing measures to promote safety awareness and provide training to healthcare professionals on proper handling of these kind of medical devices.
There are also additional efforts taken by the clinical practitioners to ensure that the medical equipment’s they are using are properly sterilized. Therefore, an overall efforts taken by the healthcare professionals on educating and training their clinical staff on improving the overall quality of healthcare of the MENA region contributes to the growth in demand of syringes and cannula.
Principal Consultant
The MENA syringes & cannula industry recorded a CAGR of 4.7% during the historical period between 2019 and 2023. The growth of syringes & cannula market is positive as it reached a value of USD 1,503.5 million in 2023 from USD 1,181.9 million in 2019.
The syringes & cannula market experienced positive growth attributed to the rising ageing population suffering from various chronic disorders, increase in number of patients undergoing medical procedures, growing advancements in syringes and cannulas with an aim of preventing injuries at healthcare facilities and the continuously developing healthcare infrastructure. For instance, according to the World Bank the share of UAE’s ageing population i.e., above the age of 65 is projected to increase by 4.4% by 2030.
These developing healthcare infrastructure in the region has brought new job opportunities for many of the upcoming healthcare practitioners who are willing to start their career at the international forefront. For instance, according to an article published by Alpen Capital, Dubai will require an additional number of 8,300 physicians and 8,800 nurses by the year 2025.
Development of these advanced healthcare infrastructure has also made it a great spot for medical tourism. For instance, the UAE Ministry of Economy report have demonstrated that the sales of medical tourism in UAE were estimated to be USD 2.3 billion in 2021 which are projected to grow to by 17.1% between 2021 and 2025. These growing healthcare infrastructure has led to an increase in demand for medical supplies that are advanced, safe and have reduced risk of needle-stick injuries.
To meet this growing demand many of the national players who are exporting medical supplies to the MENA region have introduced advanced syringes and cannula technology that are safely engineered. These are few of the factors that are significantly contributing to the growing adoption of syringes and cannula in the MENA market.
Tier 1 companies consist of market leaders with a market revenue of above USD 100 million and holds a market share of 15% to 20% in global market. These market leaders have high production capacities and has a wide range of product portfolio to offer in the market. These players also has strong geographical presence with their growing emphasis on expansion of their distribution network in emerging nations. Prominent companies within tier 1 include Becton, Dickinson, and Company, Cardinal Health, and B. Braun Medical Inc.
Tier 2 companies include mid-size players with revenue of USD 50 to 100 million having presence in specific countries and have ability to influence the local market. These players are have strong local network in hospital and other healthcare facilities and poses advanced technology that are required for the manufacturing of products. The companies in tier 2 include Ambu A/S, Nipro Corporation, Terumo Corporation, and Medline Industries Inc. etc.
Tier 3 includes the small-scale companies operating at the local level. These companies have customer base of local healthcare facilities. They are small-scale players and have limited market reach. Tier 3, companies are recognized as unorganized market, as they have limited production facility as compared to organized competitors.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The section below covers the industry analysis for the MENA syringes and cannula market for different countries. Market demand analysis on key countries in several countries of the MENA, including Saudi Arabia, Turkey, Algeria, Iran, Israel and others, is provided. Qatar is anticipated to grow at a maximum growth rate of 9.0% during the forecast period.
| Countries | Value CAGR (2024 to 2034) |
|---|---|
| Saudi Arabia | 5.3% |
| Turkey | 4.2% |
| UAE | 6.1% |
| Egypt | 5.4% |
| Morocco | 8.7% |
| Qatar | 9.0% |
| Kuwait | 6.9% |
Saudi Arabia syringes and cannula market is poised to exhibit a CAGR of 5.3% between 2024 and 2034 and is projected to reach USD 409.4 million by the end of 2034. The country currently holds the largest market share of 15.8% and the trend is expected to continue during the forecast period.
The rapid urbanization and economic development in the Saudi Arabia country have led to an increase in number of people following sedentary lifestyle. These increased number of people following sedentary lifestyle has led to a rising prevalence of chronic disease such as diabetes and hypertension among growing population.
In addition to this, an increase in ageing population suffering from chronic disease and comorbidities have led to an increased need of developing a robust healthcare infrastructure which is efficient to deliver an effective healthcare service to the patient population of the country.
These factors has encouraged many private healthcare facility investors to invest in construction of advanced medical facilities. These investors are also emphasizing on installation of technologically advanced medical equipment’s are further propelling the growth of the market in the region. For instance, in March 2023, HSBC Bank Middle East Limited published an article which stated that there are more than 161 healthcare projects in GCC that are under pipeline.
In addition to this, the growing emphasis of regulatory authorities on improving accessibility of healthcare facilities in the underserved areas of the region further augment the growth of the market. . In October 2022, Saudi Arabia health ministry announced that it would give a green light to over 100 projects in next five years.
Turkey currently holds around 12.4% share of the MENA syringes & cannula market. The market is anticipated to grow at a CAGR of 4.2% throughout the forecast period.
Several initiatives launched by Turkish government for improving the healthcare services and infrastructure in the country has primarily contributed to the growth of the syringes and cannula market in the country. These initiatives are majorly aimed to expand their existing healthcare facilities by constructing new hospitals and clinics.
For instance, according to an article published by the Prime Property Turkey Limited, in August 2022, Turkish president Recep Tayyip Erdogan is working on an initiative of building more hospitals in the country is underway. The initiative of building more hospitals is aimed to revitalize healthcare system for general population through city hospitals.
Moreover, the country has also emerged as a popular destination for the medical tourism as they have number of surgeons equipped with technologically advanced facilities. For instance, according to an article published by JOURNAL OF SOCIETY, ECONOMICS AND MANAGEMENT in June 2024, Türkiye has become one of the most optimal destination for medical tourism for medical treatments such as orthopedics, cardiology, and cosmetic surgery.
The section contains information about the leading segments in the industry. By product, the syringes segment accounted for a market share of 73.7% in 2023 and is anticipated to grow at a significant CAGR during the forecast period.
| Material | Syringes |
|---|---|
| Value Share (2024) | 73.7% |
The syringes segment dominates the market in terms of revenue. The segment accounted for almost 73.7% of the market share in 2024 and is projected to grow at a significant growth rate during the forecast period. The dominance in revenue share is owing to the growing adoption of syringes for the management of pain and other chronic conditions such as diabetes.
In addition to this, growing use of syringes in wide variety of medical procedures such as administration of injections, drawing blood and delivering medications makes use of syringe a staple product in the healthcare settings. Moreover, increasing use of injectable medications including vaccines and biologics due to growing focus of government on launching immunization programs for the treatment of chronic diseases further contributes to its increasing demand in the market.
In addition to this, increasing awareness of needle safety and the need to prevent needle-stick injuries have emphasized manufacturers to focus on development of syringes that have improved safety measures and are efficient for healthcare providers.
| Usage | Disposable |
|---|---|
| Value Share (2024) | 68.6% |
The disposable segment accounted for a revenue share of over 68.6% in the MENA syringes and cannula market and is poised to expand at a significant CAGR across the forecast period. The development of safety measures like passive needle guards and improved retractable needle systems is addressing the concern of needle-stick injuries, making disposable syringes more attractive.
The segment has witnessed a significant growth owing to its increased adoption among healthcare facilities for preventing cross-contamination of any disease among patients. Moreover, use of disposable syringes eliminates the cost of sterilization which makes it a cost-effective solution for healthcare facilities and contributes to its increased adoption.
The number of vaccination drives sponsored by government and non-government organizations has increased significantly in MENA, resulting in increased demand for disposable syringes and cannula.
Key players operating in the syringes and cannula market are emphasizing on expansion of their geographical presence by expanding their direct sales channel and distributors network. Key players have also involved in making strategic collaboration for launch of their new products to the market.
Recent Industry Developments in MENA Syringes and Cannula Market
In terms of product, the industry is divided into syringes (disposable hypodermic syringes, auto disposable syringes, safety syringes, prefilled syringes, insulin syringes), and cannula (neonatal cannula, straight cannula, winged cannula, cannula with wings & port, cannula with integrated stop cock, nasal cannula)
In terms of usage, the industry is segregated into reusable and disposable.
The industry is classified distribution channel as institutional sales (hospitals, ambulatory surgical centres, office-based clinics, skilled nursing facilities & long term care centres, diagnostic laboratories and academic and research institutions), retail sales (retail pharmacies, drug stores, retail stores {hypermarket/supermarket}, online sales)
Key countries of MENA, including Algeria, Iran, Israel, Egypt, UAE, Saudi Arabia, Morocco, Kuwait, Qatar, Turkey, and Rest of MENA have been covered in the report.
The MENA syringes & cannula industry is projected to witness CAGR of 5.9% between 2024 and 2034.
The MENA syringes & cannula industry stood at USD 1,503.5 million in 2023.
The MENA syringes & cannula industry is anticipated to reach USD 2,824.7 million by 2034 end.
Saudi Arabia is set to record the highest revenue share of 15.8% in the assessment period.
The key players operating in the MENA syringes & cannula industry include Ambu A/S, Becton, Dickinson, and Company, Cardinal Health, B. Braun Medical Inc., Medline Industries Inc., Nipro Corporation, Terumo Corporation, Hindustan Syringes & Medical Devices Ltd., Schott Kaisha Private Limited, Edwards Lifesciences Corporation, Abu Dhabi National Industrial Projects Company, Middle East Medical, Medtronic Plc., The 3M Company, Honeywell International Inc., Kimberly-Clark Corporation, DuPont de Nem
1. Executive Summary
2. Industry Introduction, including Taxonomy and Market Definition
3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
4. Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections
5. Market Analysis 2019 to 2023 and Forecast 2024 to 2034
5.1. By Product
5.2. By Usage
5.3. By Distribution Channel
5.4. By Country
6. Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Product
6.1. Syringes
6.1.1. Disposable Hypodermic Syringes
6.1.2. Auto Disposable Syringes
6.1.3. Safety Syringes
6.1.4. Prefilled Syringes
6.1.5. Insulin Syringes
6.2. Cannula
6.2.1. Neonatal Cannula
6.2.2. Straight Cannula
6.2.3. Winged Cannula
6.2.4. Cannula with Wings & Port
6.2.5. Cannula with Integrated Stop Cock
6.2.6. Nasal Cannula
7. Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Usage
7.1. Reusable
7.2. Disposable
8. Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Distribution Channel
8.1. Institutional Sales
8.1.1. Hospitals
8.1.2. Ambulatory Surgical Centres
8.1.3. Office-based Clinics
8.1.4. Skilled Nursing Facilities & Long Term Care Centres
8.1.5. Diagnostic Laboratories
8.1.6. Academic and Research Institutions
8.2. Retail Sales
8.2.1. Retail Pharmacies
8.2.2. Drug Stores
8.2.3. Retail Stores (Hypermarket/Supermarket)
8.2.4. Online Sales
9. Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Country
9.1. Algeria
9.2. Iran
9.3. Israel
9.4. Egypt
9.5. UAE
9.6. Saudi Arabia
9.7. Morocco
9.8. Kuwait
9.9. Qatar
9.10. Turkey
9.11. Rest of MENA
10. Middle East and North Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
11. Sales Forecast 2024 to 2034 by Product, Usage, and Distribution Channel for 30 Countries
12. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
13. Company Profile
13.1. Ambu A/S
13.2. Becton, Dickinson, and Company
13.3. Cardinal Health
13.4. B. Braun Medical Inc.
13.5. Medline Industries Inc.
13.6. Nipro Corporation
13.7. Terumo Corporation
13.8. Hindustan Syringes & Medical Devices Ltd.
13.9. Schott Kaisha Private Limited
13.10. Edwards Lifesciences Corporation
13.11. Abu Dhabi National Industrial Projects Company
13.12. Middle East Medical
13.13. Medtronic Plc.
13.14. The 3M Company
13.15. Honeywell International Inc.
13.16. Kimberly-Clark Corporation
13.17. DuPont de Nemours, Inc.
13.18. Top Glove Corporation Bhd
13.19. Ansell Limited
13.20. Hartalega Holdings Berhad
Explore Healthcare Insights
View Reports
MENA Syringes & Cannula Market
